中国组织工程研究

中国组织工程研究 ›› 2012, Vol. 16 ›› Issue (35): 6636-6640.doi: 10.3969/j.issn.2095-4344.2012.35.033

• 骨与关节临床实践 clinical practice of the bone and joint • 上一篇    下一篇

髋部骨质疏松性骨折患者骨质疏松药物治疗现状调查

王 红1，李明升2，陈海翎1，邓丽丽1，张 权3，邓 微1，李 伟1   

  1. 1北京积水潭医院，1内分泌科，3创伤骨科，北京市100035；
    2解放军总参谋部管理保障部中心门诊部，北京市 100087  
  • 收稿日期:2012-04-25 修回日期:2012-06-11 出版日期:2012-08-26 发布日期:2013-07-12
  • 通讯作者: 陈海翎，博士，主治医师，北京积水潭医院内分泌科，北京市 100035 hailing_chen@263.net
  • 作者简介:王红，女，1966年出生，河北省衡水市人，汉族，1988年河北张家口医学院毕业，副主任医师，主要从事骨质疏松方面的研究。 wanghong_43@sohu.com

Survey on osteoporosis medical therapy in patients with osteoporotic hip fracture

Wang Hong1, Li Ming-sheng2, Chen Hai-ling1, Deng Li-li1, Zhang Quan3, Deng Wei1, Li Wei1   

  1. 1Department of Endocrinology, 3Department of Orthopedic trauma, Beijing Jishuitan Hospital, Beijing 100035, China;
    2Department of Center Out-patient, General Staff Headquarters Management & Security Department of Chinese PLA, Beijing 100087, China
  • Received:2012-04-25 Revised:2012-06-11 Online:2012-08-26 Published:2013-07-12
  • Contact: Chen Hai-ling, Doctor, Attending physician, Department of Endocrinology, Beijing Jishuitan Hospital, Beijing 100035, China hailing_chen@263.net
  • About author:Wang Hong, Associate chief physician, Department of Endocrinology, Beijing Jishuitan Hospital, Beijing 100035, China wanghong_43@sohu.com

PDF

684

被引次数

2

摘要：

背景：髋部骨质疏松是其骨折的主要原因。
目的：调查50岁以上骨质疏松髋部骨折患者骨质疏松相关评估和药物治疗现状。
方法：通过电子病历回顾及电话随访的方式，对于2009-07/2010-12在北京积水潭医院住院的50岁及以上、骨质疏松髋部骨折患者进行调查。完成有效调查484例，调查内容包括骨密度检查、骨质疏松相关药物的应用现状以及患者对骨质疏松的知晓率。
结果与结论：患者中骨折前曾进行过骨密度检查的患者仅为13例(2.7%)，曾经用过骨质疏松相关药物的46例(9.5%)，骨折住院期间为93例(19.2%)和219例(45.2%)，随访期间分别为14例(2.9%)，96例(19.8%)。随访期仅骨质疏松相关药物应用率显著高于住院前(P=0.000)。患者或其家人对其患有骨质疏松症知晓率仅为45.9%，主要获取途径来自于医务人员占54%。提示大多数骨质疏松髋部骨折患者在发生骨折前和康复期没有接受骨质疏松相关检查，骨质疏松的知晓率低，治疗率更低。

关键词: 骨质疏松, 髋部骨折, 药物, 治疗, 知晓率, 组织工程

Abstract:

BACKGROUND: Osteoporosis of the hip is the main reason for the osteoporotic fracture.
OBJECTIVE: To investigate whether osteoporosis was evaluated and treated appropriately in patients more than 50 years old with hip osteoporotic fracture．
METHODS: The patients suffered from hip osteoporotic fracture and treated in Beijing Jishuitan Hospital during July 2009 to December 2010 were enrolled. Information were collected from electronic medical records and telephone follow-up, and 484 patients were investigated, the survey including bone mineral density examination, application status of anti-osteoporosis drug and awareness rate of osteoporosis.
RESULTS AND CONCLUSION: Among 484 patients, bone mineral density examination was performed only in 13 patients (2.7%), 46 patients (9.5%) treated with anti-osteoporosis drugs before fracture, 93 patients (19.2%) received bone mineral density examination and 219 patients (45.2%) were treated with anti-osteoporosis drugs during hospitalization, 14 patients (2.9%) received bone mineral density examination and 96 patients (19.8%) were treated with anti-osteoporosis drugs during hospitalization during follow-up. The application rate of anti-osteoporosis drugs during follow-up was significantly higher than that before hospitalization (P = 0.000). The awareness rate for the patients and their families was 45.9%, and 54% of the patients obtained the information from medical staff. Most patients with hip osteoporotic fracture do not receive adequate anti-osteoporosis drugs or appropriate evaluation before fracture and during rehabilitation, so the awareness rate and the treatment rate of osteoporosis was low．

中图分类号: